-
Most Popular
VVUS
3 Pharmaceutical Stocks to Sell Now
The overall ratings of three pharmaceutical stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Sell Now
This week, the ratings of three Pharmaceutical stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Sell Now
The ratings of three Pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Huge Healthcare Trends Can Fatten Your Portfolio
Healthcare concerns in the U.S. are being addressed by companies in the industry. These 3 issues can lead investors to stock opportunities
3 Pharmaceutical Stocks to Sell Now
This week, the ratings of three Pharmaceutical stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Sell Now
This week, the ratings of three Pharmaceutical stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Sell Now
The ratings of three Pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Sell Now
This week, the overall grades of three Pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Sell Now
The ratings of three Pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Sell Now
This week, the ratings of three Pharmaceutical stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Sell Now
This week, the ratings of three Pharmaceutical stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Sell Now
The ratings of three Pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Sell Now
For the current week, the overall ratings of three Pharmaceutical stocks are worse, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Employment Data Hoists Stocks: Thursday’s IP Market Recap
Solid news on the employment front helped drive the broader market higher. Heading north were LNKD, BBRY and GRPN, among others.
Automakers Take the Wheel: Wednesday’s IP Market Recap
Automakers' strong August sales pushed the major auto stocks higher Wednesday amid a smooth, positive day for the broader markets.
5 Short-Lived CEO Stints
These five CEOs were hired and fired in the blink of an eye -- whether because of bad performance, lying or even more extreme circumstances.
Merger Mania Takes Over: Tuesday’s IP Market Recap
Merger and buyout news for Verizon, Vodafone, Microsoft and Nokia led the headline news as investors bid up markets broadly to start the fall.
3 Pharmaceutical Stocks to Sell Now
This week, the ratings of three Pharmaceutical stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Sell Now
This week, the overall grades of three Pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
